Pictured: Robot hand holding microscope, pill bottles and DNA/Taylor Tieden for BioSpace
Xaira Therapeutics launched April 23 with $1 billion behind it to apply artificial intelligence to drug discovery and development. It was the largest initial commitment from backer ARCH Venture Partners in the biotech-focused…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
dōTERRA Announces David Stirling’s Return as Chief Executive Officer
PLEASANT GROVE, Utah, Feb. 3, 2026 /PRNewswire/ — dōTERRA International, the global leader in essential oils and natural wellness, announced that company founder David Stirling has officially returned to his role as Chief Executive Officer, […]
STAT+: The FDA questions underlying Utah’s AI prescription pilot
Brittany Trang talks to STAT’s Mario Aguilar about Doctronic’s Utah AI pilot and issues facing AI doctors, in this AI Prognosis. Click here to view original post Click Here to Publish/Feature Your Company or Product […]
Introducing Sentient Tixel to the US: the First and Only Thermal-Mechanical Action Technology for Skin Resurfacing
Proprietary technology with a proven track record in Europe for over a decade gives Aesthetics Industry greater ability to reduce patient pain and social downtime PARK CITY, Utah, May 15, 2023 /PRNewswire/ — Sentient®, LLC […]
